Panitumumab. en las nuevas guías de CCRm - page 34

EGFR antibodies should be
used in combination with:
°
FOLFOX/FOLFIRI [I, A],
°
capecitabine-based and bolus
5-FU based regimens should
not be combined with EGFR
antibodies
1...,24,25,26,27,28,29,30,31,32,33 35,36,37,38,39,40,41,42,43,44,...47
Powered by FlippingBook